{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T13:19:04Z","timestamp":1794057544603,"version":"4.8.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-025-02653-z","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:43:15Z","timestamp":1752136995000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The effects of estimated glucose disposal rate and high sensitivity C-reactive protein on risk of incident cardiovascular diseases in middle-aged and elderly Chinese adults: a nationwide prospective cohort study"],"prefix":"10.1186","volume":"24","author":[{"given":"Linghao","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangping","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"issue":"4","key":"2653_CR1","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1161\/CIR.0000000000001256","volume":"150","author":"KE Joynt Maddox","year":"2024","unstructured":"Joynt Maddox KE, Elkind M, Aparicio HJ, et al. Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050-Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association. Circulation. 2024;150(4):e65\u201388.","journal-title":"Circulation"},{"issue":"25","key":"2653_CR2","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990\u20132019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"key":"2653_CR3","doi-asserted-by":"crossref","unstructured":"GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795\u2013820.","DOI":"10.1016\/S1474-4422(21)00252-0"},{"key":"2653_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154766","volume":"119","author":"MA Hill","year":"2021","unstructured":"Hill MA, Yang Y, Zhang L, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119: 154766.","journal-title":"Metabolism"},{"issue":"1","key":"2653_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/j.2040-4603.2013.tb00484.x","volume":"3","author":"CK Roberts","year":"2013","unstructured":"Roberts CK, Hevener AL, Barnard RJ. Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr Physiol. 2013;3(1):1\u201358.","journal-title":"Compr Physiol"},{"issue":"1","key":"2653_CR6","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41392-022-01073-0","volume":"7","author":"M Li","year":"2022","unstructured":"Li M, Chi X, Wang Y, Setrerrahmane S, Xie W, Xu H. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct Target Ther. 2022;7(1):216.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"2653_CR7","doi-asserted-by":"publisher","first-page":"626","DOI":"10.2337\/diabetes.49.4.626","volume":"49","author":"KV Williams","year":"2000","unstructured":"Williams KV, Erbey JR, Becker D, Arslanian S, Orchard TJ. Can clinical factors estimate insulin resistance in type 1 diabetes. Diabetes. 2000;49(4):626\u201332.","journal-title":"Diabetes"},{"issue":"8","key":"2653_CR8","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.2337\/dc12-1693","volume":"36","author":"EJ Epstein","year":"2013","unstructured":"Epstein EJ, Osman JL, Cohen HW, Rajpathak SN, Lewis O, Crandall JP. Use of the estimated glucose disposal rate as a measure of insulin resistance in an urban multiethnic population with type 1 diabetes. Diabetes Care. 2013;36(8):2280\u20135.","journal-title":"Diabetes Care"},{"issue":"1","key":"2653_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12933-024-02570-y","volume":"24","author":"J Liao","year":"2025","unstructured":"Liao J, Wang L, Duan L, et al. Association between estimated glucose disposal rate and cardiovascular diseases in patients with diabetes or prediabetes: a cross-sectional study. Cardiovasc Diabetol. 2025;24(1):13.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"2653_CR10","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1111\/dom.16132","volume":"27","author":"H Huang","year":"2025","unstructured":"Huang H, Xiong Y, Zhou J, et al. The predictive value of estimated glucose disposal rate and its association with myocardial infarction, heart failure, atrial fibrillation and ischemic stroke. Diabetes Obes Metab. 2025;27(3):1359\u201368.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"2653_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13098-025-01659-y","volume":"17","author":"X Liang","year":"2025","unstructured":"Liang X, Lai K, Li X, Gui S, Xing Z, Li Y. U-shaped relationship of estimated glucose disposal rate with cardiovascular disease risk in cardiovascular-kidney-metabolic syndrome stages 0\u20133: a population-based prospective study. Diabetol Metab Syndr. 2025;17(1):85.","journal-title":"Diabetol Metab Syndr"},{"issue":"19","key":"2653_CR12","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1001\/jama.2009.1672","volume":"302","author":"EV Kuklina","year":"2009","unstructured":"Kuklina EV, Yoon PW, Keenan NL. Trends in high levels of low-density lipoprotein cholesterol in the United States, 1999\u20132006. JAMA. 2009;302(19):2104\u201310.","journal-title":"JAMA"},{"issue":"3","key":"2653_CR13","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1001\/jamacardio.2016.4396","volume":"2","author":"A Rosinger","year":"2017","unstructured":"Rosinger A, Carroll MD, Lacher D, Ogden C. Trends in Total Cholesterol, Triglycerides, and Low-Density Lipoprotein in US Adults, 1999\u20132014. JAMA Cardiol. 2017;2(3):339\u201341.","journal-title":"JAMA Cardiol"},{"issue":"15","key":"2653_CR14","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1001\/jama.2012.13260","volume":"308","author":"MD Carroll","year":"2012","unstructured":"Carroll MD, Kit BK, Lacher DA, Shero ST, Mussolino ME. Trends in lipids and lipoproteins in US adults, 1988\u20132010. JAMA. 2012;308(15):1545\u201354.","journal-title":"JAMA"},{"issue":"9493","key":"2653_CR15","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","volume":"366","author":"C Baigent","year":"2005","unstructured":"Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366(9493):1267\u201378.","journal-title":"Lancet"},{"issue":"1","key":"2653_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/eurheartj\/ehaa099","volume":"42","author":"PR Lawler","year":"2021","unstructured":"Lawler PR, Bhatt DL, Godoy LC, et al. Targeting cardiovascular inflammation: next steps in clinical translation. Eur Heart J. 2021;42(1):113\u201331.","journal-title":"Eur Heart J"},{"issue":"6","key":"2653_CR17","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.jacc.2015.11.037","volume":"67","author":"PM Ridker","year":"2016","unstructured":"Ridker PM. A Test in Context: High-Sensitivity C-Reactive Protein. J Am Coll Cardiol. 2016;67(6):712\u201323.","journal-title":"J Am Coll Cardiol"},{"issue":"9709","key":"2653_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","volume":"375","author":"S Kaptoge","year":"2010","unstructured":"Kaptoge S, Di Angelantonio E, Lowe G, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375(9709):132\u201340.","journal-title":"Lancet"},{"issue":"40","key":"2653_CR19","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1093\/eurheartj\/ehy533","volume":"39","author":"PE Penson","year":"2018","unstructured":"Penson PE, Long DL, Howard G, et al. Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study. Eur Heart J. 2018;39(40):3641\u201353.","journal-title":"Eur Heart J"},{"issue":"8","key":"2653_CR20","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2012.9624","volume":"308","author":"J Yeboah","year":"2012","unstructured":"Yeboah J, McClelland RL, Polonsky TS, et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA. 2012;308(8):788\u201395.","journal-title":"JAMA"},{"issue":"1","key":"2653_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014;43(1):61\u20138.","journal-title":"Int J Epidemiol"},{"issue":"11","key":"2653_CR22","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1093\/aje\/kwz170","volume":"188","author":"X Chen","year":"2019","unstructured":"Chen X, Crimmins E, Hu PP, et al. Venous Blood-Based Biomarkers in the China Health and Retirement Longitudinal Study: Rationale, Design, and Results From the 2015 Wave. Am J Epidemiol. 2019;188(11):1871\u20137. https:\/\/doi.org\/10.1093\/aje\/kwz170.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"2653_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jacc.2023.04.052","volume":"82","author":"J Morales","year":"2023","unstructured":"Morales J, Handelsman Y. Cardiovascular Outcomes in Patients With Diabetes and Kidney Disease: JACC Review Topic of the Week. J Am Coll Cardiol. 2023;82(2):161\u201370.","journal-title":"J Am Coll Cardiol"},{"key":"2653_CR24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pharmthera.2016.11.013","volume":"172","author":"A Faria","year":"2017","unstructured":"Faria A, Persaud SJ. Cardiac oxidative stress in diabetes: Mechanisms and therapeutic potential. Pharmacol Ther. 2017;172:50\u201362.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"2653_CR25","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12933-024-02244-9","volume":"23","author":"C Cui","year":"2024","unstructured":"Cui C, Liu L, Qi Y, et al. Joint association of TyG index and high sensitivity C-reactive protein with cardiovascular disease: a national cohort study. Cardiovasc Diabetol. 2024;23(1):156. https:\/\/doi.org\/10.1186\/s12933-024-02244-9.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2653_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11886-025-02192-0","volume":"27","author":"FM Yusoff","year":"2025","unstructured":"Yusoff FM, Kajikawa M, Yamaji T, et al. A Body Shape Index as a Simple Anthropometric Marker for the Risk of Cardiovascular Events. Curr Cardiol Rep. 2025;27(1):46.","journal-title":"Curr Cardiol Rep"},{"issue":"1","key":"2653_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12933-025-02575-1","volume":"24","author":"J Zhang","year":"2025","unstructured":"Zhang J, Sun Z, Li Y, et al. Association between the cumulative estimated glucose disposal rate and incident cardiovascular disease in individuals over the age of 50 years and without diabetes: data from two large cohorts in China and the United States. Cardiovasc Diabetol. 2025;24(1):51.","journal-title":"Cardiovasc Diabetol"},{"issue":"7347","key":"2653_CR28","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature10146","volume":"473","author":"P Libby","year":"2011","unstructured":"Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473(7347):317\u201325.","journal-title":"Nature"},{"issue":"16","key":"2653_CR29","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.106.676890","volume":"116","author":"I Tabas","year":"2007","unstructured":"Tabas I, Williams KJ, Bor\u00e9n J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation. 2007;116(16):1832\u201344.","journal-title":"Circulation"},{"issue":"4","key":"2653_CR30","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","volume":"118","author":"MR Bennett","year":"2016","unstructured":"Bennett MR, Sinha S, Owens GK. Vascular Smooth Muscle Cells in Atherosclerosis. Circ Res. 2016;118(4):692\u2013702.","journal-title":"Circ Res"},{"issue":"3","key":"2653_CR31","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","volume":"145","author":"KJ Moore","year":"2011","unstructured":"Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145(3):341\u201355.","journal-title":"Cell"},{"issue":"12","key":"2653_CR32","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1161\/CIRCULATIONAHA.117.029870","volume":"136","author":"F Crea","year":"2017","unstructured":"Crea F, Libby P. Acute Coronary Syndromes: The Way Forward From Mechanisms to Precision Treatment. Circulation. 2017;136(12):1155\u201366.","journal-title":"Circulation"},{"issue":"25","key":"2653_CR33","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1016\/j.jacc.2011.08.055","volume":"58","author":"N Cristell","year":"2011","unstructured":"Cristell N, Cianflone D, Durante A, et al. High-sensitivity C-reactive protein is within normal levels at the very onset of first ST-segment elevation acute myocardial infarction in 41% of cases: a multiethnic case-control study. J Am Coll Cardiol. 2011;58(25):2654\u201361.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2653_CR34","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","volume":"11","author":"NG Frangogiannis","year":"2014","unstructured":"Frangogiannis NG. The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol. 2014;11(5):255\u201365.","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"2653_CR35","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jacc.2023.05.035","volume":"82","author":"PM Burger","year":"2023","unstructured":"Burger PM, Koudstaal S, Mosterd A, et al. C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular Disease. J Am Coll Cardiol. 2023;82(5):414\u201326.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2653_CR36","doi-asserted-by":"publisher","first-page":"774","DOI":"10.2337\/diabetes.55.03.06.db05-1417","volume":"55","author":"S Devaraj","year":"2006","unstructured":"Devaraj S, Glaser N, Griffen S, Wang-Polagruto J, Miguelino E, Jialal I. Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes. 2006;55(3):774\u20139.","journal-title":"Diabetes"},{"issue":"4","key":"2653_CR37","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1007\/s00125-006-0522-y","volume":"50","author":"C D'Alessandris","year":"2007","unstructured":"D\u2019Alessandris C, Lauro R, Presta I, Sesti G. C-reactive protein induces phosphorylation of insulin receptor substrate-1 on Ser307 and Ser 612 in L6 myocytes, thereby impairing the insulin signalling pathway that promotes glucose transport. Diabetologia. 2007;50(4):840\u20139.","journal-title":"Diabetologia"},{"issue":"1","key":"2653_CR38","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/hep.24011","volume":"53","author":"L Xi","year":"2011","unstructured":"Xi L, Xiao C, Bandsma RH, Naples M, Adeli K, Lewis GF. C-reactive protein impairs hepatic insulin sensitivity and insulin signaling in rats: role of mitogen-activated protein kinases. Hepatology. 2011;53(1):127\u201335.","journal-title":"Hepatology"},{"issue":"7","key":"2653_CR39","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1172\/JCI29069","volume":"116","author":"SE Shoelson","year":"2006","unstructured":"Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116(7):1793\u2013801.","journal-title":"J Clin Invest"},{"issue":"1","key":"2653_CR40","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12933-019-0913-2","volume":"18","author":"Y Yan","year":"2019","unstructured":"Yan Y, Li S, Liu Y, et al. Temporal relationship between inflammation and insulin resistance and their joint effect on hyperglycemia: the Bogalusa Heart Study. Cardiovasc Diabetol. 2019;18(1):109.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"2653_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3005","volume":"34","author":"JV Stidsen","year":"2018","unstructured":"Stidsen JV, Henriksen JE, Olsen MH, et al. Pathophysiology-based phenotyping in type 2 diabetes: A clinical classification tool. Diabetes Metab Res Rev. 2018;34(5): e3005.","journal-title":"Diabetes Metab Res Rev"},{"key":"2653_CR42","doi-asserted-by":"crossref","unstructured":"Gyldenkerne C, Knudsen JS, Olesen K, et al. Nationwide trends in cardiac risk and mortality in patients with incident type 2 diabetes: a danish cohort study. Diabetes Care. 2021;44(10):2353\u201360.","DOI":"10.2337\/dc21-0383"},{"issue":"1","key":"2653_CR43","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1186\/s12877-022-03689-x","volume":"22","author":"X Ren","year":"2022","unstructured":"Ren X, Jiang M, Han L, Zheng X. Estimated glucose disposal rate and risk of cardiovascular disease: evidence from the China Health and Retirement Longitudinal Study. BMC Geriatr. 2022;22(1):968.","journal-title":"BMC Geriatr"},{"issue":"1","key":"2653_CR44","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12933-024-02396-8","volume":"23","author":"HM He","year":"2024","unstructured":"He HM, Xie YY, Chen Q, et al. The additive effect of the triglyceride-glucose index and estimated glucose disposal rate on long-term mortality among individuals with and without diabetes: a population-based study. Cardiovasc Diabetol. 2024;23(1):307.","journal-title":"Cardiovasc Diabetol"},{"issue":"10022","key":"2653_CR45","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","volume":"387","author":"D Ettehad","year":"2016","unstructured":"Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957\u201367.","journal-title":"Lancet"},{"issue":"9","key":"2653_CR46","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.2337\/dc11-0329","volume":"34","author":"H Wang","year":"2011","unstructured":"Wang H, Shara NM, Lee ET, et al. Hemoglobin A1c, fasting glucose, and cardiovascular risk in a population with high prevalence of diabetes: the strong heart study. Diabetes Care. 2011;34(9):1952\u20138.","journal-title":"Diabetes Care"},{"issue":"8","key":"2653_CR47","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.2337\/dc21-0292","volume":"44","author":"JC Prentice","year":"2021","unstructured":"Prentice JC, Mohr DC, Zhang L, et al. Increased Hemoglobin A(1c) Time in Range Reduces Adverse Health Outcomes in Older Adults With Diabetes. Diabetes Care. 2021;44(8):1750\u20136.","journal-title":"Diabetes Care"},{"key":"2653_CR48","doi-asserted-by":"crossref","unstructured":"Peters SA, Visseren FL, Grobbee DE. Biomarkers. Screening for C-reactive protein in CVD prediction. Nat Rev Cardiol. 2013:10(1):12\u20134.","DOI":"10.1038\/nrcardio.2012.164"},{"key":"2653_CR49","doi-asserted-by":"crossref","unstructured":"Rutter MK, Meigs JB, Sullivan LM, Sr DRB, Wilson PW. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation. 2004:110(4):380\u20135.","DOI":"10.1161\/01.CIR.0000136581.59584.0E"},{"issue":"5","key":"2653_CR50","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.2337\/dc22-1353","volume":"46","author":"A Gedebjerg","year":"2023","unstructured":"Gedebjerg A, Bjerre M, Kjaergaard AD, et al. CRP, C-Peptide, and Risk of First-Time Cardiovascular Events and Mortality in Early Type 2 Diabetes: A Danish Cohort Study. Diabetes Care. 2023;46(5):1037\u201345.","journal-title":"Diabetes Care"},{"issue":"10","key":"2653_CR51","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41569-023-00877-z","volume":"20","author":"ND Wong","year":"2023","unstructured":"Wong ND, Sattar N. Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention. Nat Rev Cardiol. 2023;20(10):685\u201395.","journal-title":"Nat Rev Cardiol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02653-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02653-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02653-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T02:21:42Z","timestamp":1757211702000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02653-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2653"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02653-z","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"21 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants received approval from the Ethics Review Committee of Peking University. Written informed consent was obtained from all patients and participants prior to their involvement in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"234"}}